C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2002
11/28/2002	WO2001095919A3 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
11/28/2002	WO2001085764A3 Regulation of human p2y-like g protein-coupled receptor
11/28/2002	WO2001081415A3 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/28/2002	WO2001079275A3 STAPHYLOCOCCAL GENE, vgaC, CONFERRING RESISTANCE TO STREPTOGRAMIN A AND RELATED COMPOUNDS
11/28/2002	WO2001074993A3 A novel polypeptide - human zinc finger protein 17 and the polynucleotide encoding said polypeptide
11/28/2002	WO2001070954A9 Regulation of human nerve growth factor-elated g protein-coupled receptor
11/28/2002	WO2001068911A3 Diagnosis of diseases associated with the cell cycle
11/28/2002	WO2001059459A3 Compositions and methods for screening therapeutic agents
11/28/2002	WO2001018021A9 B7-like polynucleotides, polypeptides, and antibodies
11/28/2002	US20020178468 Nucleotide sequences coding polypeptide for use in the transport of carbohydrates throughout plant cells
11/28/2002	US20020178464 Proton transporters and uses in plants
11/28/2002	US20020178461 Transgenic fish with tissue-specific expression
11/28/2002	US20020178460 Animal model for use as tools in genetic engineering
11/28/2002	US20020178459 Genetically engineered mammal for use in the treatment of muscle and liver disorders
11/28/2002	US20020178458 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd534 as a target
11/28/2002	US20020177700 New ras-like protein
11/28/2002	US20020177697 Immunity to trypanosomatids species
11/28/2002	US20020177696 Compositions and methods relating to breast specific genes and proteins
11/28/2002	US20020177694 Composition containing immunogenic peptide for use in the treatment, diagnosis and prevention of viral diseases and cancers
11/28/2002	US20020177692 Protein complex for use in the diagnosis, prevention and treatment of cell proliferative disorders
11/28/2002	US20020177690 Novel antimicrobial polypeptides and methods of use
11/28/2002	US20020177688 Genetically engineered polypeptide for use in the treatment of infections, inflammation, hematopietic, bone and wound disorders
11/28/2002	US20020177569 Tuberculosis vaccine
11/28/2002	US20020177568 Enzymatic nucleic acid treatment of diseases or conditions related to levels of NF-kappa B
11/28/2002	US20020177567 Comprising a HER-2/neu extracellular domain fused to a HER-2/neu phosphorylation domain, wherein the protein is capable of producing an immune response in a warm-blooded animal.
11/28/2002	US20020177565 Toso proteins and related molecules which have an inhibitory effect on TNF mediated apoptosis
11/28/2002	US20020177564 DNA construct comprising said exogenous gene under the control of an ecdysone response element; and a modified ecdysone receptor which, in the presence of a ligand therefor, binds to said ecdysone response element
11/28/2002	US20020177557 Peptides and mimetics are based on the N-terminal tetrapeptide of IAP-binding proteins, such as Smac/DIABLO, Hid, Grim and Reaper, which interact with a specific surface groove of IAP.
11/28/2002	US20020177555 Precementum- and / or cementum - derived chemotactic factor (CCTF) of tooth of mammalia, process for purifying the same, and drug for accelerating adhesion of new connective tissue, comprising the same as active ingredient
11/28/2002	US20020177554 Novel peptides for use in treatment of T-cell mediated cartilage destruction in autoimmune diseases
11/28/2002	US20020177553 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/28/2002	US20020177552 Colon tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions; alternatively, antigen presenting cell that expresses a colon tumor protein, or a T cell that is specific for cells expressing such a
11/28/2002	US20020177551 Mammalian cell receptor useful in the treatment of cancer which binds tumor associated lipids wherein said binding induces anergy or apoptosis in said T cells and antigen presenting cells.
11/28/2002	US20020177550 Administering to the subject a therapeutically effective amount of a form of soluble Receptor for Advanced Glycation Endproducts (RAGE).
11/28/2002	US20020177549 Which regulate cellular guidance and physiology, and related nucleic acids.
11/28/2002	US20020177547 Nucleic acid molecule encoding a tumor-associated antigen and a peptide comprising a region corresponding to a putative cytotoxic T cell, helper T cell or B cell epitope of the antigen and/or cells pulsed with such peptidse
11/28/2002	US20020177545 Compositions and methods for treating gonadotrophin related illnesses
11/28/2002	US20020177544 Adenoviral transfer vector for the gene transport of a dna sequence
11/28/2002	US20020177231 Polypeptide for use in the humans therapeutic and diagnostics
11/28/2002	US20020177230 Generating genetically engineered viral genome; obtain clones, incubate with restriction enzymes, recover nucleotide sequence, ligate and generate viral genome
11/28/2002	US20020177222 Replication competent AAV helper functions
11/28/2002	US20020177216 Culturing preferential mammalian virus; obtain mammalian cells, infect cell with virus, culture cells and recover viral particles
11/28/2002	US20020177215 Methods for producing purified adenoviral vectors
11/28/2002	US20020177214 Hepp, a novel gene with a role in hematopoietic and neural development
11/28/2002	US20020177212 Polypeptide that interacts with heat shock proteins
11/28/2002	US20020177209 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
11/28/2002	US20020177207 Tsg101-interacting proteins and use thereof
11/28/2002	US20020177201 Channel protein for use in the treatment of nervous system, brain and epileptic
11/28/2002	US20020177200 Moraxella catarrahalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
11/28/2002	US20020177194 Polypeptide for use in the treatment of immunological, allergies and autoimmune diseases
11/28/2002	US20020177193 Growth factor homolog zvegf3
11/28/2002	US20020177192 Chimeric protein for use in the treatment of vision defects
11/28/2002	US20020177191 Compound for use inthe diagnosis and treatment of cancer, viral, asthmatic, autoimmune, organ transplant rejection and infections
11/28/2002	US20020177190 Nucleotide sequences coding polypeptide for use in the treatment of hypertension and vision defects
11/28/2002	US20020177189 Novel fluorescent proteins
11/28/2002	US20020177188 IL-17 homologous polypeptides and therapeutic uses thereof
11/28/2002	US20020177187 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
11/28/2002	US20020177185 Production of adenine nucleotide translocator (ant), novel ant lgands and screening assays therrfor
11/28/2002	US20020177178 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies
11/28/2002	US20020177177 Interaction between cyclin D1 and steroid receptor co-activators and uses thereof in assays
11/28/2002	US20020177173 Glycoprotein for use in the treatment of thrombosis
11/28/2002	US20020177166 Binding motif of a receptor
11/28/2002	US20020177165 Secreted and transmembrane polypeptides and nucleic acids encoding
11/28/2002	US20020177164 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/28/2002	US20020177163 Polypeptide for use in the diagnosis and treatment of nervous system disorders
11/28/2002	US20020177162 Detection of receptor agonist; obtain sample containing receptor, incubate with modulator, monitor signal from receptor
11/28/2002	US20020177158 Detection of preferential protein in sample; obtain pool of proteins, incubate with probe, detect signal from probe, recover proteins
11/28/2002	US20020177152 COX 1-interacting proteins and use thereof
11/28/2002	US20020177151 Detect nucleotide sequences associate with metabolic disorders; obtain nucleotide sequences samples, incubate with probes, detect signal from probe, absence of signal indicates mutation and possible metabolic disorder
11/28/2002	US20020177150 Nucleoside composition for use as tool in human therapeutics and diagnositcs
11/28/2002	US20020177148 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of stroke and nervous system disorders
11/28/2002	US20020177140 Compositions and methods relating to prostate specific genes and proteins
11/28/2002	US20020177128 Variant of LAV viruses
11/28/2002	US20020177125 Polypeptide for use in the treatment of viral disease
11/28/2002	US20020177124 Nucleotide sequences coding polypeptide for use in the detection, prevention and diagnosis viral diseases
11/28/2002	US20020176871 A nucleic acids encoding an intracellular mature virion antigen and at least one nucleic acid encoding an extracellular enveloped virion antigen of a poxvirus
11/28/2002	US20020176870 Methods and compositions useful for stimulating an immune response
11/28/2002	US20020176869 Hepatitus A virus vaccines
11/28/2002	US20020176868 Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same
11/28/2002	US20020176867 Fusion proteins of the immunodominant antigens ESAT-6 and Ag85B from Mycobacterium tuberculosis or homologues, and the vaccine based on fusion protein, which induces efficient immunological memory
11/28/2002	US20020176866 The peptide analog is at least seven amino acids long and derived from residues 83 to 99 of human myelin basic protein and analogs are altered from native sequence atleast at positin 91, 95 and 97
11/28/2002	US20020176865 Genetic engineering
11/28/2002	US20020176864 Two-domain MHC polypeptides include MHC( major histocompatibility complex) class II-based molecules that covalently linked beta 1 and alpha 1 domains, and MHC class I-based molecules that covalently linked alpha-1 and alpha-2
11/28/2002	US20020176863 A carrier fused to an amino-terminal peptide fragment of streptococcal M protein having an epitope that elicits opsonic antibodies to group A streptococci serotype without eliciting crossreactive antiboides to mammalian tissue antigens
11/28/2002	US20020176862 A protein (Sm 16.8) with anti-inflammatory, and immunomodulatory functions was identified and isolated from the excretory/secretions of a human parasite, Schistosoma manson
11/28/2002	US20020176860 A polypeptide providing cytotoxicity, being fused to an apoptin rendering the fusion protein functionally available in aberrant cells and not functionally available in non-aberrant cells
11/28/2002	US20020176853 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/28/2002	US20020176851 Aministering to mammal an effective amount of therapeutic cells, expressing a membrane-bound, proteinaceous chimeric receptor, capable recognizing and binding target cell or infective agent; antitumor therapy
11/28/2002	US20020176846 Storage stable powder compositions of interleukin-4 receptor
11/28/2002	US20020176819 Gastrin receptor-avid peptide conjugates
11/28/2002	DE10212572A1 Bone formation controlling composition, especially for treatment of osteoporosis, containing ANK-pyrophosphate channel modulator, e.g. human ANK gene variant or probenecid
11/28/2002	DE10123958A1 Identifying ligands for G protein-coupled receptors, useful for treating cardiovascular disease, by using calcium-sensitive fluorophores in cells expressing G alpha proteins
11/28/2002	DE10123133A1 New proteins binding specifically to the ED-b fibronectin domain, are cell adhesion and proliferation mediators useful e.g. in screening tests
11/28/2002	DE10122140A1 Rekombinante Fusionsproteine und deren Trimere Recombinant fusion proteins and their trimers
11/28/2002	CA2755964A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
11/28/2002	CA2464343A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
11/28/2002	CA2457853A1 Benzophenone-linked crf and crf-like peptides for covalent labeling of corticotropin-releasing factor (crf) binding protein
11/28/2002	CA2450677A1 A novel intein and uses thereof
11/28/2002	CA2448668A1 Modulation of cd200 receptors
11/28/2002	CA2448360A1 Modulation of cell division by an early mitotic inhibitor protein

1 ... 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 ... 2916